ARCHIVES

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

This article is from The Cancer Letter archive.

Vol. 40 No. 06 | February 7, 2014

Download PDF Visit The Full Archive

Related Articles

Immunotherapy Shrinks Tumors In Phase I Study at St. Jude

May 30, 2014

Early Detection Network Completes Initial Funding From NCI.

June 2, 2000

DCT Bard Okays Concepts for BRMP Contract Programs

June 22, 1984

Contracts Awarded For $30 Million Heavy Smokers Clinical Trials

October 10, 1986

AACR, ASCO Continue Growth, Drop Idea Of “Cancer Week”

July 1, 1988

GI Intergroup called a model for proposed scientific steering committees.

June 10, 2005